In this edition:
Posoleucel for preventing post-SCT viral infections
Sequential conditioning and allogeneic SCT vs. remission induction chemotherapy in relapsed/refractory AML
Intravenous efgartigimod for primary ITP
Consolidation blinatumomab improves OS in new B-ALL with MRD-negative remission
Oral iptacopan monotherapy in PNH with residual anaemia
Post-transplant cyclophosphamide, tacrolimus and mycophenolate for GVHD prophylaxis in reduced-intensity conditioning
Global SCT utilisation for AML
Real-world frontline RVD, Rd or VCD for elderly transplant-ineligible MM
Somatic mutation landscape of hereditary haematopoietic malignancies associated with RUNX1, GATA2 and DDX41 variants
Phase 1B/2 study to investigate novel pre-emptive therapies in AML
Please login below to download this issue (PDF)